|Bid||130.80 x 200|
|Ask||131.75 x 1000|
|Day's Range||130.38 - 132.12|
|52 Week Range||96.93 - 139.00|
|PE Ratio (TTM)||49.29|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Biogen (BIIB) has had a good, though not great year. Is it time to add it to your portfolio? Shares of Biogen have gained 11.5% so far this year, and while that's better than the S&P 500's 10.3% rise during ...
How do I love thee, Celgene? Let me count the ways.
We discussed the products that contribute to the growth of Pfizer’s (PFE) revenues in 2Q17. Let's now take a look at the products that have impacted revenue growth in 2Q17.